🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for IRE

Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma NCT07832006Phase 21 site📍 Beijing Shunda Du · Tests: Irreversible Electroporation, Lenvatinib, Sintilimab Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer NCT04276857NA2 sites📍 Regina📍 Saskatoon University of Saskatchewan · Tests: Irreversible electroporation (NanoKnife® ) IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus NCT07799922NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: IRE, PLACEBO COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases NCT06185556Phase 2, Phase 31 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Irreversible electroporation, Stereotactic body radiotherapy Focal Therapy for Localized Prostate Cancer NCT06270043n/a1 site📍 La Jolla University of California, San Diego · Tests: Focal Therapy Transperineal Irreversible Electroporation for Benign Prostatic Hyperplasia NCT06867315NA10 sites📍 Hefei📍 Fuzhou📍 Quanzhou First Affiliated Hospital of Zhejiang University · Tests: Composite steep-pulse therapeutic device (CNP-III) Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study NCT07263451NA2 sites📍 Hangzhou📍 Hangzhou Tian'an Jiang · Tests: IRE by stunning pulse therapy device Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal) NCT06491056n/a1 site📍 Singapore Singapore General Hospital · Tests: Focal Therapy for Prostate Cancer Registry for Prostate Cancer Focal Therapy NCT07792590n/a1 site📍 Hong Kong The University of Hong Kong · Tests: Focal Therapy for Prostate Cancer IRE After Chemotherapy for Locally Advanced Pancreatic Cancer NCT07799935NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: IRE, PLACEBO IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy NCT07306273Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Irreversible electroporation, Dual-Function Antibody PD-1/CTLA-4 American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry NCT02674100n/a16 sites📍 Birmingham📍 San Diego📍 Denver University of Louisville · Tests: Registry ¹⁸F-PSMA-1007 PET-CT-Directed Focal Therapy for MRI-Invisible Prostate Cancer NCT07788625NA1 site📍 Hong Kong The University of Hong Kong · Tests: Focal Therapy for Prostate Cancer Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM NCT06630624Phase 1, Phase 21 site📍 Amsterdam M.R. Meijerink · Tests: IP-001 PULSed Field ablAtion of coloRectal Polyps NCT06317727n/a1 site📍 London King's College Hospital NHS Trust · Tests: Irreversible Electroporation using EndoVE(Endoscopic Vacuum Electrode) and electrical pulses generated using ePORE(elec… A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer NCT06451445NA1 site📍 Toronto University Health Network, Toronto · Tests: Irreversible Electroporation (NanoKnife) Focal or Radical Therapy: a Lesion-based Molecular Evaluation in Prostate Cancer NCT07282808NA1 site📍 Singapore Singapore General Hospital · Tests: Molecular Evaluation for Risk of Recurrence after FT Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study NCT07328243NA3 sites📍 Guangzhou📍 Hangzhou📍 Hangzhou Tian'an Jiang · Tests: Irreversible Electroporation (IRE) Ablation Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma NCT03484299Phase 11 site📍 Louisville University of Louisville · Tests: Irreversible Electroporation (IRE), Gemcitabine, FOLFIRINOX Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System- NCT06937996n/a1 site📍 Englewood Englewood Hospital and Medical Center · Tests: NanoKnife HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar Cholangiocarcinoma NCT07795619NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: IRE+chemotherapy, chemotherapy Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a NCT07678489NA2 sites📍 Düsseldorf📍 Siegen Sami-Ramzi Leyh-Bannurah · Tests: ToP-RAP Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma NCT03080974Phase 21 site📍 Louisville University of Louisville · Tests: Nivolumab, Irreversible Electroporation Prostate Irreversible Electroporation Study NCT06886321NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Prostate Irreversible Electroporation Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer NCT07548164Phase 38 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: NanoKnife System, Stereotactic Body Radiation Therapy Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) NCT07782164n/a1 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Irreversible electroporation Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer NCT06205849Phase 11 site📍 La Jolla University of California, San Diego · Tests: IRE + intratumoral mitazalimab (CD40 antibody) injection, NanoKnife
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy